Bastiaan Moraal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bastiaan Moraal has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Frederik Barkhof
Amsterdam UMC, Location VUmc
6 shared publications Hugo Vrenken
Department of Radiology, MS Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands
5 shared publicationsJeroen J. G. Geurts
Department of Radiology, MS Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands
5 shared publicationsPetra J. W. Pouwels
Department of Physics and Medical Technology, MS Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands
5 shared publications- Ronald A. van Schijndel
VU University Medical Center
5 shared publications Dominik S. Meier
Center for Neurological Imaging, Departments of Radiology and Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
4 shared publications
Latest Publications
- 26 April 2010
- Published by Wiley in Annals of Neurology
- Vol. 67 (5) , 667-675
Long‐interval T2‐weighted subtraction magnetic resonance imaging: A powerful new outcome measure in multiple sclerosis trials
Objective: To compare long‐interval T2‐weighted subtraction (T2w‐Sub) imaging with monthly gadolinium‐enhanced T1‐weighted (Gd‐T1w) imaging for (1) detection of active lesions, (2) assessment of treatment efficacy, and (3) statistical power, in a multiple sclerosis (MS), phase 2, clinical trial setting.Methods: Magnetic resonance imaging (MRI) data over 9 months from 120 patients (61 treatment, 59 placebo) from the oral temsirolimus trial were used. T2w‐Sub images were scored for active lesions, independent of the original reading of the monthly Gd‐T1w images. Treatment efficacy was evaluated using the nonparametric Mann‐Whitney U test, and parametric negative binomial (NB)‐regression and power calculations were conducted.Results: Datasets from 116 patients (58 treatment, 58 placebo) were evaluated. The mean number of T2w‐Sub lesions in the treatment group was 3.0 (±4.6) versus 5.9 (±8.8) for placebo; the mean cumulative number of new Gd‐T1w lesions in the treatment group was 5.5(±9.1) versus 9.1(±17.2) for placebo. T2w‐Sub imaging showed increased power to assess treatment efficacy compared with Gd‐T1w imaging, when evaluated by Mann‐Whitney U test (p = 0.017 vs p = 0.177), or NB‐regression without (p = 0.011 vs p = 0.092) or with baseline adjustment (p < 0.001 vs p = 0.002). Depending on the magnitude of the simulated treatment effect, sample size calculations showed reductions of 22 to 34% in the number of patients (translating into reductions of 81–83% in the number of MRI scans) needed to detect a significant treatment effect in favor of T2w‐Sub imaging.Interpretation: Compared with monthly Gd‐T1w imaging, long‐interval T2w‐Sub MRI exhibited increased power to assess treatment efficacy, and could greatly increase the cost‐effectiveness of phase 2 MS trials by limiting the number of patients, contrast injections, and MRI scans needed. ANN NEUROL 2010;67:667–675
- 26 April 2010
- Published by Wiley in Annals of Neurology
- Vol. 67 (5) , 667-675
Long‐interval T2‐weighted subtraction magnetic resonance imaging: A powerful new outcome measure in multiple sclerosis trials
Objective: To compare long‐interval T2‐weighted subtraction (T2w‐Sub) imaging with monthly gadolinium‐enhanced T1‐weighted (Gd‐T1w) imaging for (1) detection of active lesions, (2) assessment of treatment efficacy, and (3) statistical power, in a multiple sclerosis (MS), phase 2, clinical trial setting.Methods: Magnetic resonance imaging (MRI) data over 9 months from 120 patients (61 treatment, 59 placebo) from the oral temsirolimus trial were used. T2w‐Sub images were scored for active lesions, independent of the original reading of the monthly Gd‐T1w images. Treatment efficacy was evaluated using the nonparametric Mann‐Whitney U test, and parametric negative binomial (NB)‐regression and power calculations were conducted.Results: Datasets from 116 patients (58 treatment, 58 placebo) were evaluated. The mean number of T2w‐Sub lesions in the treatment group was 3.0 (±4.6) versus 5.9 (±8.8) for placebo; the mean cumulative number of new Gd‐T1w lesions in the treatment group was 5.5(±9.1) versus 9.1(±17.2) for placebo. T2w‐Sub imaging showed increased power to assess treatment efficacy compared with Gd‐T1w imaging, when evaluated by Mann‐Whitney U test (p = 0.017 vs p = 0.177), or NB‐regression without (p = 0.011 vs p = 0.092) or with baseline adjustment (p < 0.001 vs p = 0.002). Depending on the magnitude of the simulated treatment effect, sample size calculations showed reductions of 22 to 34% in the number of patients (translating into reductions of 81–83% in the number of MRI scans) needed to detect a significant treatment effect in favor of T2w‐Sub imaging.Interpretation: Compared with monthly Gd‐T1w imaging, long‐interval T2w‐Sub MRI exhibited increased power to assess treatment efficacy, and could greatly increase the cost‐effectiveness of phase 2 MS trials by limiting the number of patients, contrast injections, and MRI scans needed. ANN NEUROL 2010;67:667–675
- 1 April 2010
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 255 (1) , 154-163
Improved Detection of Active Multiple Sclerosis Lesions: 3D Subtraction Imaging
Three-dimensional subtraction imaging, in comparison with two-dimensional subtraction imaging, showed a lower propensity for artifacts, resulting in improved image quality and better ability to detect small, active multiple sclerosis lesions. PurposeTo examine the benefits of using near-isotropic single-slab three-dimensional (3D) magnetic resonance (MR) imaging for the creation of subtraction images and to evaluate their performance in the detection of active multiple sclerosis (MS) brain lesions in comparison with two-dimensional (2D) subtraction images. Materials and MethodsThe study protocol was approved by the local ethics review board and all subjects gave written informed consent before investigation. Three-dimensional MR sequences, including double inversion-recovery, fluid-attenuated inversion recovery, T2-weighted, and T1-weighted magnetization-prepared rapid acquisition gradient-echo (MP-RAGE), and corresponding 2D sequences were performed twice in 14 patients (eight women, six men; mean age, 37.6 years) with MS and nine age-matched healthy control subjects (three women, six men; mean age, 31.7 years). Active lesions were scored by two independent raters, followed by a consensus reading. Lesion counts were evaluated by using negativ...
- 1 April 2010
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 255 (1) , 154-163
Improved Detection of Active Multiple Sclerosis Lesions: 3D Subtraction Imaging
Three-dimensional subtraction imaging, in comparison with two-dimensional subtraction imaging, showed a lower propensity for artifacts, resulting in improved image quality and better ability to detect small, active multiple sclerosis lesions. PurposeTo examine the benefits of using near-isotropic single-slab three-dimensional (3D) magnetic resonance (MR) imaging for the creation of subtraction images and to evaluate their performance in the detection of active multiple sclerosis (MS) brain lesions in comparison with two-dimensional (2D) subtraction images. Materials and MethodsThe study protocol was approved by the local ethics review board and all subjects gave written informed consent before investigation. Three-dimensional MR sequences, including double inversion-recovery, fluid-attenuated inversion recovery, T2-weighted, and T1-weighted magnetization-prepared rapid acquisition gradient-echo (MP-RAGE), and corresponding 2D sequences were performed twice in 14 patients (eight women, six men; mean age, 37.6 years) with MS and nine age-matched healthy control subjects (three women, six men; mean age, 31.7 years). Active lesions were scored by two independent raters, followed by a consensus reading. Lesion counts were evaluated by using negativ...
- Open Access
- 1 November 2009
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 66 (11) , 1345-1352
Magnetic Resonance Imaging Predictors of Conversion to Multiple Sclerosis in the BENEFIT Study
In 85% to 90% of patients with multiple sclerosis (MS), the onset of symptoms occurs as a clinically isolated syndrome (CIS).1 Long-term follow-up studies of patients with a CIS have shown that the syndrome eventually converts to clinically definite MS (CDMS) in only 38% to 68% of patients2 and that abnormal magnetic resonance (MR) images at disease presentation are a powerful prognostic tool, as 56% to 88% of patients having a CIS with abnormal images progress to CDMS compared with 19% to 24% with normal images.3-6 In 2001, the modified Barkhof criteria7,8 were incorporated into the diagnostic McDonald criteria,9 allowing earlier diagnosis of MS based on MR imaging–derived measures. The MR imaging criteria included locations in the brain where demyelination typically occurs in MS (periventricular, juxtacortical, and infratentorial) and yielded high specificity and adequate sensitivity in predicting conversion to CDMS.
- 1 November 2009
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 66 (11) , 1345-1352
Open AccessMagnetic Resonance Imaging Predictors of Conversion to Multiple Sclerosis in the BENEFIT Study
In 85% to 90% of patients with multiple sclerosis (MS), the onset of symptoms occurs as a clinically isolated syndrome (CIS).1 Long-term follow-up studies of patients with a CIS have shown that the syndrome eventually converts to clinically definite MS (CDMS) in only 38% to 68% of patients2 and that abnormal magnetic resonance (MR) images at disease presentation are a powerful prognostic tool, as 56% to 88% of patients having a CIS with abnormal images progress to CDMS compared with 19% to 24% with normal images.3-6 In 2001, the modified Barkhof criteria7,8 were incorporated into the diagnostic McDonald criteria,9 allowing earlier diagnosis of MS based on MR imaging–derived measures. The MR imaging criteria included locations in the brain where demyelination typically occurs in MS (periventricular, juxtacortical, and infratentorial) and yielded high specificity and adequate sensitivity in predicting conversion to CDMS.
- 1 September 2009
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 22 (1_suppl) , 33-42
Multi-Contrast, Isotropic, Single-Slab 3D MR Imaging in Multiple Sclerosis
To describe signal and contrast properties of an isotropic, single-slab 3D dataset [double inversion-recovery (DIR), fluid-attenuated inversion recovery (FLAIR), T2, and T1-weighted magnetization prepared rapid acquisition gradient-echo (MPRAGE)] and to evaluate its performance in detecting multiple sclerosis (MS) brain lesions compared to 2D T2-weighted spin-echo (T2SE). All single-slab 3D sequences and 2D-T2SE were acquired in 16 MS patients and 9 age-matched healthy controls. Lesions were scored independently by two raters and characterized anatomically. Two-tailed Bonferroni-corrected Student's t-tests were used to detect differences in lesion detection between the various sequences per anatomical area after log-transformation. In general, signal and contrast properties of the 3D sequences enabled improved detection of MS brain lesions compared to 2D-T2SE. Specifically, 3D-DIR showed the highest detection of intracortical and mixed WM-GM lesions, whereas 3D-FLAIR showed the highest total number of WM lesions. Both 3D-DIR and 3D-FLAIR showed the highest number of infratentorial lesions. 3D-T2 and 3D-MPRAGE did not improve lesion detection compared to 2D-T2SE. Multi-contrast, isotropic, single-slab 3D MRI allowed an improved detection of both GM and WM lesions compared to 2D-T2SE. A selection of single-slab 3D contrasts, for example, 3D-FLAIR and 3D-DIR, could replace 2D sequences in the radiological practice.
- 1 September 2009
- Published by SAGE Publications in The Neuroradiology Journal
- Vol. 22 (1_suppl) , 33-42
Multi-Contrast, Isotropic, Single-Slab 3D MR Imaging in Multiple Sclerosis
To describe signal and contrast properties of an isotropic, single-slab 3D dataset [double inversion-recovery (DIR), fluid-attenuated inversion recovery (FLAIR), T2, and T1-weighted magnetization prepared rapid acquisition gradient-echo (MPRAGE)] and to evaluate its performance in detecting multiple sclerosis (MS) brain lesions compared to 2D T2-weighted spin-echo (T2SE). All single-slab 3D sequences and 2D-T2SE were acquired in 16 MS patients and 9 age-matched healthy controls. Lesions were scored independently by two raters and characterized anatomically. Two-tailed Bonferroni-corrected Student's t-tests were used to detect differences in lesion detection between the various sequences per anatomical area after log-transformation. In general, signal and contrast properties of the 3D sequences enabled improved detection of MS brain lesions compared to 2D-T2SE. Specifically, 3D-DIR showed the highest detection of intracortical and mixed WM-GM lesions, whereas 3D-FLAIR showed the highest total number of WM lesions. Both 3D-DIR and 3D-FLAIR showed the highest number of infratentorial lesions. 3D-T2 and 3D-MPRAGE did not improve lesion detection compared to 2D-T2SE. Multi-contrast, isotropic, single-slab 3D MRI allowed an improved detection of both GM and WM lesions compared to 2D-T2SE. A selection of single-slab 3D contrasts, for example, 3D-FLAIR and 3D-DIR, could replace 2D sequences in the radiological practice.
- 1 February 2009
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 250 (2) , 506-514
Subtraction MR Images in a Multiple Sclerosis Multicenter Clinical Trial Setting
Purpose: To explore the applicability of subtraction magnetic resonance (MR) images to (a) detect active multiple sclerosis (MS) lesions, (b) directly quantify lesion load change, and (c) detect treatment effects (distinguish treatment arms) in a placebo-controlled multicenter clinical trial by comparing the subtraction scheme with a conventional pair-wise comparison of nonregistered MR images. Materials and Methods: Forty-six pairs of MR studies in 40 patients (31 women; mean age, 31.9 years) from a multicenter clinical trial were used. The clinical trial was approved by local ethics review boards, and all subjects gave written informed consent. Active MS lesions were scored by two independent raters, and lesion load measurements were conducted by using semiautomated software. Lesion counts were evaluated by using the Wilcoxon signed rank test, interrater agreement was evaluated by using the intraclass correlation coefficient (ICC), and treatment (interferon beta-1b) effect was evaluated by using the Man...
- 1 February 2009
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 250 (2) , 506-514
Subtraction MR Images in a Multiple Sclerosis Multicenter Clinical Trial Setting
Purpose: To explore the applicability of subtraction magnetic resonance (MR) images to (a) detect active multiple sclerosis (MS) lesions, (b) directly quantify lesion load change, and (c) detect treatment effects (distinguish treatment arms) in a placebo-controlled multicenter clinical trial by comparing the subtraction scheme with a conventional pair-wise comparison of nonregistered MR images. Materials and Methods: Forty-six pairs of MR studies in 40 patients (31 women; mean age, 31.9 years) from a multicenter clinical trial were used. The clinical trial was approved by local ethics review boards, and all subjects gave written informed consent. Active MS lesions were scored by two independent raters, and lesion load measurements were conducted by using semiautomated software. Lesion counts were evaluated by using the Wilcoxon signed rank test, interrater agreement was evaluated by using the intraclass correlation coefficient (ICC), and treatment (interferon beta-1b) effect was evaluated by using the Man...
- Open Access
- 29 May 2008
- Published by Springer Nature in European Radiology
- Vol. 18 (10) , 2311-2320
Multi-contrast, isotropic, single-slab 3D MR imaging in multiple sclerosis
To describe signal and contrast properties of an isotropic, single-slab 3D dataset [double inversion-recovery (DIR), fluid-attenuated inversion recovery (FLAIR), T2, and T1-weighted magnetization prepared rapid acquisition gradient-echo (MPRAGE)] and to evaluate its performance in detecting multiple sclerosis (MS) brain lesions compared to 2D T2-weighted spin-echo (T2SE). All single-slab 3D sequences and 2D-T2SE were acquired in 16 MS patients and 9 age-matched healthy controls. Lesions were scored independently by two raters and characterized anatomically. Two-tailed Bonferroni-corrected Student’s t-tests were used to detect differences in lesion detection between the various sequences per anatomical area after log-transformation. In general, signal and contrast properties of the 3D sequences enabled improved detection of MS brain lesions compared to 2D-T2SE. Specifically, 3D-DIR showed the highest detection of intracortical and mixed WM-GM lesions, whereas 3D-FLAIR showed the highest total number of WM lesions. Both 3D-DIR and 3D-FLAIR showed the highest number of infratentorial lesions. 3D-T2 and 3D-MPRAGE did not improve lesion detection compared to 2D-T2SE. Multi-contrast, isotropic, single-slab 3D MRI allowed an improved detection of both GM and WM lesions compared to 2D-T2SE. A selection of single-slab 3D contrasts, for example, 3D-FLAIR and 3D-DIR, could replace 2D sequences in the radiological practice.
- 29 May 2008
- Published by Springer Nature in European Radiology
- Vol. 18 (10) , 2311-2320
Open AccessMulti-contrast, isotropic, single-slab 3D MR imaging in multiple sclerosis
To describe signal and contrast properties of an isotropic, single-slab 3D dataset [double inversion-recovery (DIR), fluid-attenuated inversion recovery (FLAIR), T2, and T1-weighted magnetization prepared rapid acquisition gradient-echo (MPRAGE)] and to evaluate its performance in detecting multiple sclerosis (MS) brain lesions compared to 2D T2-weighted spin-echo (T2SE). All single-slab 3D sequences and 2D-T2SE were acquired in 16 MS patients and 9 age-matched healthy controls. Lesions were scored independently by two raters and characterized anatomically. Two-tailed Bonferroni-corrected Student’s t-tests were used to detect differences in lesion detection between the various sequences per anatomical area after log-transformation. In general, signal and contrast properties of the 3D sequences enabled improved detection of MS brain lesions compared to 2D-T2SE. Specifically, 3D-DIR showed the highest detection of intracortical and mixed WM-GM lesions, whereas 3D-FLAIR showed the highest total number of WM lesions. Both 3D-DIR and 3D-FLAIR showed the highest number of infratentorial lesions. 3D-T2 and 3D-MPRAGE did not improve lesion detection compared to 2D-T2SE. Multi-contrast, isotropic, single-slab 3D MRI allowed an improved detection of both GM and WM lesions compared to 2D-T2SE. A selection of single-slab 3D contrasts, for example, 3D-FLAIR and 3D-DIR, could replace 2D sequences in the radiological practice.